• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Franklin Biotechnology Discovery Adv (FTDZX)

    169.42 Up 6.20(3.80%) Dec 17
    Prev Close:163.22
    YTD Return*:32.13%
    Net Assets*:1.70B
    Yield*:N/A

    * As of 30-Nov-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for FTDZX at this time.

    Top Holdings

    Symbol% AssetsYTD Return %
    CELG9.4436.36
    GILD8.4436.07
    BIIB7.3217.42
    AMGN5.0850.53
    MDVN3.9177.51

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:1.7B
    Category:Health
    Annual Report Expense Ratio (net):0.80%

    Performance & Risk

    YTD Return:32.13%
    5y Avg Return:30.72%
    Rank in Category (ytd):11
    % Rank in Category (ytd):8.73%
    Beta (3y):0.79
    Morningstar Risk Rating:4

    Fund Summary

    The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. It predominantly invests in equity securities, primarily common stock. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of foreign or U.S. issuer. It is non-diversified. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback